Hematopoietic stem cell mobilization therapy accelerates recovery of renal function independent of stem cell contribution
- PMID: 15829714
- DOI: 10.1681/ASN.2004080678
Hematopoietic stem cell mobilization therapy accelerates recovery of renal function independent of stem cell contribution
Abstract
Acute renal failure and tubular cell loss as a result of ischemia constitute major challenges in renal pathophysiology. Increasing evidence suggests important roles for bone marrow stem cells in the regeneration of renal tissue after injury. This study investigated whether the enhanced availability of hematopoietic stem cells, induced by stem cell factor and granulocyte colony-stimulating factor, to the injured kidney provides an adequate strategy for stem cell-based therapy to counteract renal ischemia/reperfusion injury. It is interesting that cytokine treatment before injury resulted in significant enhancement of function recovery of the kidney. This, however, was not due to increased incorporation of tubular epithelial cells from bone marrow origin. Importantly, cytokine treatment resulted in impaired influx of granulocytes into the injured kidney. Although cytokine treatment improved renal function rapidly after ischemic injury, the results show that the underlying mechanism likely is not based on stem cell transdifferentiation but rather on altered inflammatory kinetics.
Similar articles
-
Enhanced mobilization of bone marrow cells does not ameliorate renal fibrosis.Nephrol Dial Transplant. 2008 Feb;23(2):483-91. doi: 10.1093/ndt/gfm607. Epub 2007 Nov 7. Nephrol Dial Transplant. 2008. PMID: 17989101
-
Cellular therapy of kidney diseases.Semin Dial. 2009 Nov-Dec;22(6):629-35. doi: 10.1111/j.1525-139X.2009.00654.x. Semin Dial. 2009. PMID: 20017833 Review.
-
Mouse kidney progenitor cells accelerate renal regeneration and prolong survival after ischemic injury.Stem Cells. 2010 Mar 31;28(3):573-84. doi: 10.1002/stem.310. Stem Cells. 2010. PMID: 20099318
-
Administration of hematopoietic cytokines in the subacute phase after cerebral infarction is effective for functional recovery facilitating proliferation of intrinsic neural stem/progenitor cells and transition of bone marrow-derived neuronal cells.Circulation. 2006 Feb 7;113(5):701-10. doi: 10.1161/CIRCULATIONAHA.105.563668. Circulation. 2006. PMID: 16461843
-
Stem cell therapy for the kidney?Am J Ther. 2009 May-Jun;16(3):247-56. doi: 10.1097/MJT.0b013e3181800591. Am J Ther. 2009. PMID: 19092639 Review.
Cited by
-
Update of acute kidney injury: intensive care nephrology.Hippokratia. 2011 Jan;15(Suppl 1):53-68. Hippokratia. 2011. PMID: 21897760 Free PMC article.
-
Focal adhesion kinase signaling mediates acute renal injury induced by ischemia/reperfusion.Am J Pathol. 2011 Dec;179(6):2766-78. doi: 10.1016/j.ajpath.2011.08.025. Epub 2011 Oct 5. Am J Pathol. 2011. PMID: 21982831 Free PMC article.
-
Effects of chronic alcohol exposure on ischemia-reperfusion-induced acute kidney injury in mice: the role of β-arrestin 2 and glycogen synthase kinase 3.Exp Mol Med. 2017 Jun 23;49(6):e347. doi: 10.1038/emm.2017.76. Exp Mol Med. 2017. PMID: 28642577 Free PMC article.
-
Protective outcomes of low-dose doxycycline on renal function of Wistar rats subjected to acute ischemia/reperfusion injury.Biochim Biophys Acta Mol Basis Dis. 2018 Jan;1864(1):102-114. doi: 10.1016/j.bbadis.2017.10.005. Epub 2017 Oct 5. Biochim Biophys Acta Mol Basis Dis. 2018. PMID: 28987762 Free PMC article.
-
Unilateral Renal Ischemia-Reperfusion as a Robust Model for Acute to Chronic Kidney Injury in Mice.PLoS One. 2016 Mar 23;11(3):e0152153. doi: 10.1371/journal.pone.0152153. eCollection 2016. PLoS One. 2016. PMID: 27007127 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
